Side Effects and Safety Across all published research, ipamorelin has demonstrated a favorable safety profile: No significant cortisol or prolactin elevation at therapeutic doses No meaningful appetite stimulation Mild and transient side effects including headache, flushing, and injection site irritation No serious adverse events reported in published clinical trials at standard doses The main limitation is the absence of long-term safety data from large-scale human studies
Cao sm t n : Cn bg n ti t n, gi tnh trg b h, v lm m nm
An isoelectric point (pI) of 5.8, and net charges of +2.8 and 14.7 at pH 5.5 and pH 7.4, respectively, were calculated for the albumin variants (Supplementary Table 3)
For autoimmune patients whose conditions have a gut component, which includes most of them to varying degrees, the local gut effects of GLP-1 receptor activation may contribute to systemic immune improvement
Weight loss varies depending on the dose and type of medication, with differences observed in head-to-head studies [117]